Public Sector Engagement
We collaborate with government institutions to ensure equitable access to our approved products — Juxtapid® and Myalept® — for patients who depend on them. Our collaborations focus on:
Procurement through national health services (e.g., NHS England)
Participation in health technology assessments (HTAs)
Supply under named-patient and managed access programs
Public reimbursement and pricing agreements
Government Contractors
Partnering with Governments to Serve Rare Disease Communities
Aegerion Pharmaceuticals UK is proud to work with national and regional governments, public health authorities, and healthcare procurement agencies to provide essential therapies for patients with rare and ultra-rare conditions. Our commitment to transparency, regulatory excellence, and value-based care makes us a trusted partner in public health initiatives.
Bolandit massa ltriceseros in cursus turpis massa tincid untdiam.
Regulatory Compliance & Ethical Conduct
Aegerion Pharmaceuticals UK strictly adheres to all applicable UK, EU, and international laws concerning government contracting and public procurement. Our operations are guided by:
The UK Bribery Act 2010
The Public Contracts Regulations 2015
Good Distribution and Manufacturing Practice (GDP/GMP)
NHS England and NICE policy frameworks
We maintain clear documentation, audit trails, and declarations of interest to ensure full transparency and accountability in all government dealings.
